Legal & General Group PLC Glaukos Corp Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Glaukos Corp stock. As of the latest transaction made, Legal & General Group PLC holds 170,300 shares of GKOS stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170,300
Previous 140,104 21.55%
Holding current value
$21.8 Million
Previous $13.2 Million 52.57%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$89.48 - $118.35 $2.7 Million - $3.57 Million
30,196 Added 21.55%
170,300 $20.2 Million
Q1 2024

Jul 01, 2024
BUY
$76.4 - $96.33 $112,537 - $141,894
1,473 Added 1.06%
140,104 $13.2 Million
Q1 2024

May 14, 2024
BUY
$76.4 - $96.33 $325,922 - $410,943
4,266 Added 3.17%
138,631 $13.1 Million
Q4 2023

Feb 15, 2024
SELL
$59.53 - $85.11 $70,781 - $101,195
-1,189 Reduced 0.88%
134,365 $10.7 Million
Q3 2023

Nov 14, 2023
BUY
$69.23 - $79.09 $899 - $1,028
13 Added 0.01%
135,554 $10.2 Million
Q2 2023

Aug 14, 2023
SELL
$45.44 - $71.21 $120,052 - $188,136
-2,642 Reduced 1.91%
135,541 $9.65 Million
Q1 2023

May 15, 2023
SELL
$43.88 - $52.48 $1.47 Million - $1.76 Million
-33,476 Reduced 19.5%
138,183 $6.92 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $183,200 - $259,182
4,488 Added 2.68%
171,659 $7.5 Million
Q3 2022

Nov 14, 2022
SELL
$46.84 - $58.49 $818,482 - $1.02 Million
-17,474 Reduced 9.46%
167,171 $8.9 Million
Q2 2022

Aug 22, 2022
BUY
$34.86 - $63.77 $260,927 - $477,318
7,485 Added 4.22%
184,645 $8.39 Million
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $1.11 Million - $1.45 Million
-25,115 Reduced 12.42%
177,160 $10.2 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $710,000 - $1 Million
17,631 Added 9.55%
202,275 $8.99 Million
Q3 2021

Nov 15, 2021
BUY
$47.43 - $84.23 $1.2 Million - $2.13 Million
25,256 Added 15.85%
184,644 $8.89 Million
Q2 2021

Aug 12, 2021
SELL
$73.06 - $97.7 $1.72 Million - $2.3 Million
-23,548 Reduced 12.87%
159,388 $13.5 Million
Q1 2021

May 17, 2021
BUY
$70.43 - $97.42 $1.3 Million - $1.8 Million
18,500 Added 11.25%
182,936 $15.4 Million
Q4 2020

Feb 12, 2021
BUY
$48.9 - $75.26 $242,397 - $373,063
4,957 Added 3.11%
164,436 $12.4 Million
Q3 2020

Nov 13, 2020
BUY
$37.23 - $50.97 $881,234 - $1.21 Million
23,670 Added 17.43%
159,479 $7.9 Million
Q2 2020

Aug 14, 2020
BUY
$28.78 - $46.83 $444,679 - $723,570
15,451 Added 12.84%
135,809 $5.22 Million
Q1 2020

May 14, 2020
BUY
$25.53 - $70.14 $2.43 Million - $6.67 Million
95,096 Added 376.44%
120,358 $3.83 Million
Q4 2019

Feb 13, 2020
BUY
$54.18 - $65.64 $284,499 - $344,675
5,251 Added 26.24%
25,262 $1.38 Million
Q3 2019

Nov 13, 2019
BUY
$58.58 - $83.91 $149,320 - $213,886
2,549 Added 14.6%
20,011 $1.25 Million
Q2 2019

Aug 14, 2019
BUY
$63.59 - $78.71 $60,792 - $75,246
956 Added 5.79%
17,462 $1.32 Million
Q1 2019

May 15, 2019
BUY
$50.75 - $80.54 $522,522 - $829,239
10,296 Added 165.8%
16,506 $1.29 Million
Q4 2018

Feb 15, 2019
BUY
$52.18 - $67.93 $46,492 - $60,525
891 Added 16.75%
6,210 $349,000
Q3 2018

Nov 20, 2018
SELL
$38.13 - $68.37 $5,185 - $9,298
-136 Reduced 2.49%
5,319 $346,000
Q2 2018

Aug 10, 2018
BUY
$27.62 - $44.51 $4,805 - $7,744
174 Added 3.29%
5,455 $221,000
Q1 2018

May 17, 2018
SELL
$26.05 - $34.5 $48,218 - $63,859
-1,851 Reduced 25.95%
5,281 $163,000
Q4 2017

Feb 13, 2018
BUY
$24.5 - $36.01 $174,734 - $256,823
7,132
7,132 $184,000

Others Institutions Holding GKOS

# of Institutions
303
Shares Held
47M
Call Options Held
75.3K
Put Options Held
157K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.11B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email